4
Changes in Ownership
UNITED THERAPEUTICS Corp Filed Acc 0001106578-26-000160
Chairperson & CEO sold 9,500 shares at an average $534.31 ($5,075,919)
- Chairperson & CEO acquired 9,500 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
ROTHBLATT MARTINE A · Chairperson & CEO
Table I: Non-derivative
17 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-10-08 | Exercise or conversion : show line 1 in the form 10b5-1 | +9,500 | $117.76 | $1,118,720 | 333,943 | I |
| 2026-10-08 | Sale : show line 2 in the form 10b5-1 | −200 | $525.50 | $105,099 | 333,743 | I |
| 2026-10-08 | Sale : show line 3 in the form 10b5-1 | −767 | $526.66 | $403,951 | 332,976 | I |
| 2026-10-08 | Sale : show line 4 in the form 10b5-1 | −273 | $527.57 | $144,028 | 332,703 | I |
| 2026-10-08 | Sale : show line 5 in the form 10b5-1 | −200 | $528.63 | $105,725 | 332,503 | I |
| 2026-10-08 | Sale : show line 6 in the form 10b5-1 | −199 | $530.13 | $105,497 | 332,304 | I |
| 2026-10-08 | Sale : show line 7 in the form 10b5-1 | −1,061 | $531.07 | $563,468 | 331,243 | I |
| 2026-10-08 | Sale : show line 8 in the form 10b5-1 | −600 | $532.07 | $319,244 | 330,643 | I |
| Open-market sales · 9,500 sh · avg $534.31 · $5,075,919 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-10-08 | Exercise or conversion : show line 18 in the form 10b5-1 Stock Option | −9,500 | 271,410 | I |
Loading xslF345X06/primarydocument.xml…